Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Filings indexed 1,118 across all filing types
Latest filing 2024-11-13 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Unaudited Financial Statements (Consolidated & Standalone) for the second quarter and half year ended 30th September 2024
Regulatory Filings
2024-11-13 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to loss of original certificates by shareholders. It references compliance with SEBI regulations and procedures for handling lost share certificates. The content is an official notification about share certificate replacement and does not contain financial data, earnings, management discussion, or other report types. It is not a report itself but an announcement related to shareholding and share certificate management. This fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2024-11-10 English
Intimation under Regulation 39(3) - Details of loss of share certificates.
Regulatory Filings
2024-11-10 English
Board Meeting — Financial Results
Regulatory Filings
2024-10-25 English
Board Meeting — UNICHEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company…
Regulatory Filings
2024-10-25 English
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve Unaudited Financial Results ....
Regulatory Filings
2024-10-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.